Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is an interesting proposal to change the FDA approval process. Apologies if it has already been posted:
https://www.spglobal.com/marketintelligence/en/news-insights/trending/r7auraq5UKsQT1xqJUZdhw2
Nice find and thanks for posting as it good to see USF coming around. My cousin and her husband lived in Marin and the latter was diagnosed with GBM in fall of 2016. He was a year into retirement after a career teaching in a local high school where he also coached the football team. He went to USF and had his resection and went on SOC. The tumor reoccurred in early 2018 and he died several months later. I spoke to my cousin several times about DCVax and they brought it up with their oncologist. Given the outcome it is almost needless to say that the doctor was not favorably disposed to DCVax. My cousins mother (my aunt) also died from a GBM in the early '80's and her sister (my cousin) died from ovarian cancer in 2015. One wonders if DCVax was available how much tragedy would have been averted.
Yes and not a friend of ours.
You looked at the wrong part of the website:
MEDICAL ADVISORY BOARD
Timothy Cloughesy, MD, (Vice Chair)
University of California, Los Angeles
He works with Dr. Linda Liau and has been very involved in the DCVax-L trials.
Interesting to see who the vice-chair of National Brain Tumor Society medical advisory board is:
https://braintumor.org/our-mission/leadership-staff/
Looks like Marnix Bosch gave an update on the L Trial on Saturday.
The trial was never halted only new enrollments were.
Think you're right. Hopefully we will soon be reading about Direct trials in Breast and other solid tumor cancers.
I saw this on the Fox News website and then a friend posted this on FB:
https://www.winknews.com/2019/10/13/new-cancer-vaccine-shows-early-promise-kills-cancer-cells-in-patient/?fbclid=IwAR0HNmUeAlESf7OZOMFH922EzVuK1mvaV9oralXVoXIrctvyoO9XonfttHA
Must be DCVax.
Good riddance.
This won't stop unless the individuals responsible are fined or jailed.
This is the best single site for information on money in politics:
https://www.opensecrets.org
The revolving door between regulators and regulated needs to be slammed shut.
Also, Big Pharma ranks first in revolving door:
https://www.opensecrets.org/revolving/top.php?display=I
They are not capitalists they are crony capitalists and Big Pharma throws it's money around DC. How about $2.5 billion in the 10 years between 2006-2016. 2 lobbyists for every member of Congres? The opioid crisis? Epipens anyone? How about Right to Try passing but the FDA stymies the legislation by saying patients can't pay for treatment? $280 million in lobbying in 2017.
The only industry that gives more in political contributions is Finance. Wonder why the SEC and FINRA don't enforce the laws against naked short selling?
This is what NWBO is up against.
https://www.theguardian.com/us-news/2017/oct/19/big-pharma-money-lobbying-us-opioid-crisis
Huawei. It would be ashame if the Chinese reaped the benefit of DC-Vax before Americans.
https://nypost.com/2018/12/22/how-arrest-of-chinese-princess-exposes-regimes-world-domination-plot/
Great find but the link doesn't work.
The Advent facility at Sawston only takes a small percentage of the land. Sawston can still be easily sold with NWBO retaining control of the Advent facility.or perhaps something more creative like a sale-lease back.
Cognate was probably consulted before this was done. If so I wonder what they think.
Interesting - what are they and who is testing them?
One thing not to overlook is that the balance sheet of NWBO has been precarious with the company lurching from financing to financing. This lack of cash and continued dilutions has kept many potential investors away.
Today's news will likely change that as it becomes apparent to the market that this is a groundbreaking technology. The stock, in all probability, will surge and as it does warrants issued in the various deals will be converted to shares not only by long but also by shorts. A rising stock price will force many of those short the stock and long the warrants to convert to cover their positions. This will raise millions for the company.
In addition, the company recently said there was pending financing news. Hopefully, there will soon be news on this.
So a combination of warrants being exercised and a financing will substantially de-risk the company, attract new investors and likely lead to a further valuation lift for NWBO.
Thanks Senti for all your hard work and making it easier for those of us to maintain our faith in DC-Vax!
Maybe Woodford thinks he's hit on a new investment strategy - losing for the long term!
All this back on forth on this issue is hog wash. As an ex-investment manager you don't hold onto a position with this much of a loss unless there is something precluding you from trading. He hasn't even participated in one of the many deals which would have allowed him to lower his average cost.
NWBO will only be sold when Linda Power's wants it to be and it is certainly not at anything close to present valuations. The articles of the company allow for a poison pill to be adopted should a hostile bid be made.
What valuation would she sell at? I have no idea but Novocure, the manufacturer of Optune, has a market cap. of $4.6bn. If DC-Vax-L works as well as some of us think there is no reason why NWBO shouldn't have a similar valuation. For those of you out there with high risk tolerance, a pair trade of long NWBO and short NVCER could be interesting.
Also, she wouldn't have invested $5mn earlier this year.
Also, Woodford called for an additional board member to be named and suggested a man named Elliott
Leary. Mr. Leary, a former FBI agent, is an employee of Freeh Group International Solutions which is run by Louis Freeh, former head of the FBI. Mr. Freeh is also a board member of BMY. The Board met with Mr. Leary and according to a PR released on Dec. 8 2015 which said the following:
"With respect to the Board, the Company agrees with the view Neil Woodford has expressed that an additional independent board member with financial expertise can help build and advance the Company at its current stage of development. The Company has expanded the financial personnel and clinical personnel on its management team this year, and expanding the Board as well makes sense.
The Company appreciates Mr. Woodford suggesting Elliott Leary as a potential board candidate. The Board greatly enjoyed getting acquainted with Mr. Leary personally, and thanks Mr. Leary for the time he spent meeting with NW Bio’s Board members. After such meetings and further deliberations, the Board came to the conclusion that it was not a fit for Mr. Leary to join NW Bio’s Board for a number of reasons.
These reasons include the Board’s understanding that Mr. Leary has never served on any board, has no biotech experience and no pharma experience other than certain government investigations, has no experience working with companies subjected to stock manipulation, has no experience interacting with investors or helping with corporate fundraising, has not worked with companies on developing business plans or strategies, has never been asked to go on the board of any other company where he has conducted investigations, and does not anticipate playing an ongoing role on NW Bio’s board after the investigation is completed and indicated he would probably resign at that time.
The Company emphasizes that it respects Mr. Leary’s professional experiences and expertise, and greatly appreciated Mr. Leary’s willingness to talk with NW Bio’s Board on several occasions."
IMHO this connection to BMY is interesting.
Hope so. Contact your representative and encourage them to vote yes. I did.
Good observations and one group I'd like to add in is the press.
In my opinion, and this is pure speculation, Woodford was found doing something of questionable legality and the company has prevented him from buying or selling any shares. What else explains his inaction?
Regarding Susan Byah, if my memory serves me correctly, she was never put forward by the company for another term on the Board.
Anyway it is a tangled mess with lots of unsavory actors whom I hope are all exposed.
Franklin Greer is a poster boy for the swamp creatures of DC.
Also, Elliott Leary, who was put forward as an Independent Director by Neil Woodford in Nov. 2016, works for Freeh Group International.
Woodford was extremely involved in trying to reshape Northwest in 2016 not only with the above but also pushing the hiring of Ondra Partners. From various SEC filings and his almost absolute silence since then makes me wonder what his real motives were.
Also, with ever happened to Susan Byah, wife of Democratic ex-Senator Evan Byah, who was only on the Board for a year?